FdaApplication

NDA 020695

Back to search

Identifiers

Properties

PropertyValue
applicant_nameOTSUKA PHARMACEUTICAL CO LTD
application_typeNDA
approval_date1997-11-06

Products (3)

ProductActive ingredientStrengthDosage form
RAXARGREPAFLOXACIN HYDROCHLORIDEEQ 600MG BASETABLET;ORAL
RAXARGREPAFLOXACIN HYDROCHLORIDEEQ 400MG BASETABLET;ORAL
RAXARGREPAFLOXACIN HYDROCHLORIDEEQ 200MG BASETABLET;ORAL

3 products